Back to all departments
Prof. Dr. med. Michael von Bergwelt image

Department of oncology

Prof. Dr. med. Michael von Bergwelt
oncology, hematology

About the department

The department of oncology at University Hospital of the Ludwig-Maximilians-University (LMU) Munich cares for patients with malignant and blood diseases. The department participates in numerous clinical trials to give patients access to the most innovative medicines and treatment methods. A lot of national and international multi-centre academic therapy studies are initiated and managed by the department of oncology. Two modern units for allogeneic stem cell transplantation are presented in the departments. The experienced medical team of 65 doctors and 130 nurses provides a full range of diagnostic and treatment for patients and guarantees comfortable leave in a hospital. Also, a group of doctors, psychologists and therapists offer an extensive psycho-oncological care program, which includes family and children's consultation hours for the relatives of our patients. More than 3,000 inpatients and 13,000 outpatients are treated in the department per year

The department focuses on immuno-oncology, lymphomas, acute leukaemias, gastrointestinal tumours, and others. In addition, the department uses an innovative method for the treatment of malignant tumours. The treatment methods are ranged from systemic chemotherapy and targeted therapy to immunotherapy.

Show more

Treatment and diagnostic focus of the department

Diagnosis:

  • Acute leukaemias 
  • Gastrointestinal tumours 
  • Lung cancer 
  • Lymphomas 
  • Multiple myeloma 
  • Sarcomas 
  • Head and neck malignant tumours 
  • Malignant diseases of the liver, gallbladder and pancreas
  • Breast malignant tumours 
  • Pleural malignant diseases
  • Coagulopathies

Diagnostic:

  • Biopsy and cytomorphology 
  • CT with contrast
  • Cytogenetics and FISH molecular genetics (for detecting and locating a specific DNA sequence on a chromosome)
  • Immunophenotyping (to find out if malignant lymphocytes (cancer))
  • Flow cytometry (to detect and analyze the chemical and physical characteristics of cells)
  • Other procedures services 

Treatment options:

  • Surgery
  • Chemotherapy
  • Radiation therapy
  • Bone marrow transplant
  • Immunotherapy
  • Hormone therapy
  • Hyperthermia treatment (a non-invasive method of increasing tumour temperature to stimulate blood flow)
  • Targeted drug therapy
  • Cryoablation (freezing liquid is used to freeze and destroy abnormal tissue)
Show more

Doctor profile

Education

  • 2009: Board Certification in Infectiology    
  • 2008: Board Certification in Intensive Care Medicine
  • 2007: Venia Legendi in Internal Medicine („analysis of the antigen-presenting function of B cells: translation to tumour immunotherapy”)    
  • 2006: Board Certification in Internal Medicine, Hematology and Oncology
  • 2002: Dissertation: Dr. rer. nat. (PhD.) Biological and Biotechnological Analyses on CD40-activated B cells as Antigen Presenting Cells (honours, University of  Oldenburg)    
  • 2002 - 2007: Internship and Fellowship, Department I of Internal Medicine, University of Cologne (Dir.: Prof. Michael Hallek)    
  • 1999: Board Certification in Emergency Medicine, Lower Saxony    
  • 1999 - 2002: PostDoc Dana-Farber Cancer Institute, Harvard Medical School, Boston    
  • 1997: Dissertation: Dr. med. (M.D.) „Phenotypical and functional characterization of tumour-infiltrating lymphocytes in colorectal carcinoma under stimulation with Interleukin-2 and Interleukin-4 in vitro” (University of Freiburg)    
  • 1997 - 1999: Internship, Department I of Internal Medicine, University of Cologne (Dir.: Prof. Volker Diehl)    
  • 1996: United States Medical Licensure Examination (USMLE) Parts I/II    
  • 1996: Maîtrise de Sciences Biologiques et Médicales (MSBM)    
  • 1996: Approbation in Medicine    
  • 1994 - 1996: Human Biology at Université de Paris XI    
  • 1988 - 1996: Medicine at the universities of Freiburg, Münster and Paris XI  

Experience

  • 2017: Professor Hematology and Medical Oncology, Ludwig-Maximilians-University Munich, call accepted.    
  • 2016: DKH Research Consortium Immune checkpoint inhibition in Hodgkin Lymphoma, Head tumour immunology    
  • 2015: CARTime Research Consortium, (CAR T cells in Melanoma-clinical trial) Coordinating Investigator (BMBF)    
  • 2012: Professor and Chair of Hematology, ‚Ronald Finn Chair of Experimental Medicine, University of Liverpool, declined
  • 2012: Adjunct Professor of Internal Medicine, University of Cologne    
  • 2011: Senior Consultant (Leitender Oberarzt)    
  • 2008: Director, Cologne Interventional Immunology & scientific Director SCT-Program      
  • 2007: Consultant      
  • 2003 - 2009: Head, Max-Eder Junior Research Group, German Cancer Aid

Awards, memberships, publications

  • 2015: Best Abstract Award DGHO (co-author)
  • 2010: Travel Award, American Society for Blood and Marrow Transplantation
  • 2010: Basic Science Award (Abstract O84, last author), European Society for Blood and Marrow Transplantation
  • 2002: Fellow, German José Carreras-Leukemia Foundation
  • 2001: Fellow, Lymphoma Research Foundation of America
  • 1999: 'Travel Award' of the American Society of Hematology
  • 1999: Scientific Award EMSA / University of Prague
  • 1997: Mildred-Scheel Fellow, German Cancer Aid
Show more
Send request
Have any questions? Get in touch with the hospital!
Phone

Similar hospitals